この専門家をプロジェクトに採用したいですか? 見積もりを依頼 無料で。
プロフィール詳細
Dr. Riley C.に依頼
United States
Neuroscience PhD and science communicator helping researchers turn their science into stories.
プロフィール概要
専門分野
サービス
Writing
Medical Writing,
Technical Writing,
Copywriting,
General Proofreading & Editing
職務経験
Grant Specialist
Will of Iron Foundation
12月 2024 - 現在
Freelance medical writer and editor
Riley Catenacci Medical Communications
12月 2024 - 現在
Graduate Student (Ph.D.)
Johns Hopkins University School of Medicine
9月 2019 - 8月 2024
Editor-in-Chief
JHU ReVision
4月 2020 - 1月 2024
Blog Content Writer
Sparrow Science
9月 2022 - 10月 2023
Research Technician
Washington University in St. Louis
7月 2018 - 12月 2018
Undergraduate Research Assistant
Massachusetts General Hospital
7月 2017 - 4月 2018
学歴
PhD, Neuroscience
Johns Hopkins University
8月 2019 - 8月 2024
BS, Behavioral Neuroscience
Northeastern University
9月 2015 - 5月 2019
認定資格
-
Essential Skills in Medical Writing
American Medical Writers Association
https://info.amwa.org/medical-communication-essential-skills-for-success10月 2024 - 現在
-
SciComm Essentials
Kavli Institute
https://community.kavlimeetings.org/science-and-society/9月 2024 - 現在
出版物
JOURNAL ARTICLE
Larissa Jank, Riley B. Catenacci, Veronica Minney, Danny Galleguillos, Peter A. Calabresi (2024). Pharmacological modulation of inflammatory oligodendrocyte progenitor cells using three multiple sclerosis disease modifying therapies in vitro . Neurotherapeutics.
Cole A Harrington, Riley B Catenacci, Matthew D Smith, Dongeun Heo, Cecilia Miller, Keya R Meyers, Jenna Glatzer, Dwight Bergles, Peter A Calabresi (2023). MHC class I and MHC class II reporter mice enable analysis of immune oligodendroglia in mouse models of multiple sclerosis . eLife.
Marjan Gharagozloo, Riley Bannon, Peter A. Calabresi (2022). Breaking the barriers to remyelination in multiple sclerosis . Current Opinion in Pharmacology.
Simon Dujardin, Analiese R. Fernandes, Riley Bannon, Caitlin Commins, Mark De Los Santos, Tarun V. Kamath, Mansuo Hayashi, Bradley T. Hyman (2022). Tau propagation is dependent on the genetic background of mouse strains . Brain Communications.
Kathleen Schoch, Lubov Ezerskiy, Michaela M. Morhaus, Riley N. Bannon, Andrew D. Sauerbeck, Mark Shabsovich, Paymaan Jafar-nejad, Frank Rigo, Timothy Miller (2021). Acute Trem2 reduction triggers increased microglial phagocytosis, slowing amyloid deposition in mice . Proceedings of the National Academy of Sciences.
Marjan Gharagozloo, Matthew D. Smith, Elias S. Sotirchos, Jing Jin, Keya Meyers, Michelle Taylor, Thomas Garton, Riley Bannon, Hannah-Noelle Lord, Ted M. Dawson, et al. (2021). Therapeutic Potential of a Novel Glucagon-like Peptide-1 Receptor Agonist, NLY01, in Experimental Autoimmune Encephalomyelitis . Neurotherapeutics.
Susanne Wegmann, Sarah DeVos, bryan zeitler, Kim Marlen, Rachel Bennett, Marta Perez-Rando, Danny MacKenzie Jr, Qi Yu, Caitlin Commins, Riley N. Bannon, et al. (2021). Persistent repression of tau in the brain using engineered zinc finger protein transcription factors . Science Advances.
Sarah L DeVos, Bianca T Corjuc, Caitlin Commins, Simon Dujardin, Riley N Bannon, Diana Corjuc, Benjamin D Moore, Rachel E Bennett, Mehdi Jorfi, Jose A Gonzales, et al. (2018). Tau reduction in the presence of amyloid-β prevents tau pathology and neuronal death in vivo . Brain.
Sarah L. DeVos, Bianca T. Corjuc, Derek H. Oakley, Chloe K. Nobuhara, Riley N. Bannon, Alison Chase, Caitlin Commins, Jose A. Gonzalez, Patrick M. Dooley, Matthew P. Frosch, et al. (2018). Synaptic Tau Seeding Precedes Tau Pathology in Human Alzheimer's Disease Brain . Frontiers in Neuroscience.